Trials / Unknown
UnknownNCT00493493
Pore Excision, Curettage, and Injection of Cymetra for Pilonidal Disease
Pore Excision, Curettage, and Injection of a Tissue Scaffold as Treatment for Pilonidal Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Matino, James, M.D. · Individual
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Chronic pilonidal disease is a common problem with no ideal treatment. This is a prospective study that will evaluate the results of surgical pore excision, curettage, and injection of a regenerative tissue matrix, Cymetra, on patients with chronic pilonidal disease.
Detailed description
In addition, the study will evaluate the credibility and reproducibility of results within other surgeons trained to perform the procedure. Data collection will focus on post-operative wound failure, infection ratwes, analgesic requirements, time lost from work or school, wound care requirements, and 6 month recurrence rates. These outcomes will be compared to outcomes using conventional pilonidal surgical intervention using published data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | surgery (Pore Excision, Curettage, and Injection of Cymetra) |
Timeline
- Start date
- 2007-01-01
- Completion
- 2008-06-01
- First posted
- 2007-06-28
- Last updated
- 2007-06-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00493493. Inclusion in this directory is not an endorsement.